Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|November 25, 1986
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cellsG Batist, A Tulpule, B K Sinha, et al.
Journal of Molecular Endocrinology|February 15, 2001
Regulation of the gap junction connexin 43 gene by androgens in the prostateH T Huynh, L Alpert, D W Laird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2010
Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot studyM T E Puts, J Monette, V Girre, et al.
Critical Reviews in Oncology/Hematology|November 27, 2009
Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot studyM T E Puts, J Monette, V Girre, et al.
Critical Reviews in Oncology/Hematology|May 12, 2009
Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: A qualitative studyM T E Puts, V Girre, J Monette, et al.
Cancer Research|November 1, 1985
Cardiac and red blood cell glutathione peroxidase: results of a prospective randomized trial in patients on total parenteral nutritionG Batist, J Norton, A G Katki, et al.
The Journal of Biological Chemistry|August 10, 2000
Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltiprazI Jaitovitch-Groisman, N Fotouhi-Ardakani, R L Schecter, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant settingA Mamo, J Easaw, F Ibnshamsah, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933M A Alaoui-Jamali, R L Schecter, Y M Rustum, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Bevacizumab-based therapy for colorectal cancer: experience from a large Canadian cohort at the Jewish General Hospital between 2004 and 2009N Bouganim, A Mamo, D W Wasserman, et al.
Pageof 12